Page 230 - Mployee Wellness Programs News Today

To combat this issue, Joan Harvey of Evernorth stressed the importance of an omnichannel care model that leverages both in-person and virtual care. She made these comments at the HLTH conference in Las Vegas.

Type 1 diabetes patients now have a new therapeutic option for the autoimmune disorder. Provention Bio drug Tzeild has received FDA approval for delaying the onset of the most severe stage of this chronic disease.

Intermountain's former chief medical officer argued that even though hospital finances are dire, hospitals should prioritize patient experience investments. Her reasoning? People like to talk about their experiences receiving healthcare — both good and bad. When word gets around that a hospital provides non-rushed, empathetic care, more people will want to come there for treatment,

Because of bad digital experiences, 41% of patients have changed providers, the Notable survey discovered. The findings were presented at the HLTH conference in Las Vegas.

Researchers project that the U.S. healthcare industry will be short 2.1 million nurses by 2025. Including them in reimbursement models might be the most effective way to address nurses’ mass exodus from the profession, according to Rebecca Love, who is a nurse and the chief clinical officer of tech-enabled nurse staffing platform IntelyCare.

With the elevation of member experience measures in Star Ratings, CMS is signaling a broader transformation in the role payers can and should play in the care delivery system.

Following the Dobbs decision, it's vital for employers to support their employees' reproductive rights, executives from Planned Parenthood and Maven Clinic stressed at the HLTH conference in Las Vegas.

Judge Robert McBurney of Fulton County said sections of the Living Infants Fairness and Equality Act passed in 2019 were unconstitutional when drafted and enacted, therefore there is “no legal basis” for the ban which has banned abortion after six weeks. 

Cell and gene therapies are offering patients potentially curative treatments for a growing scope of diseases. Insurance companies are trying to figure out how to pay for them. Industry consultants speaking at the HLTH conference offered some strategies they see payers taking to these new therapies.

When it comes to her feelings about investing in care delivery startups, it’s a real “mixed bag” for Ulili Onovakpuri, managing partner at Kapor Capital. This is because a lot of them operate on a cash-pay model. She summarized the issue quite succinctly: there’s an incredible amount of innovation happening, but the people who could benefit the most from this type of care will be the last ones to receive it.